Home | Business News | CBJ Newsmakers | Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM) Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM) CBJ Newsmakers RecommendedAmarillo files amended and restated technical reportWeedMD Signs Exclusive Licensing Agreement to Produce Mary’s Medicinals Premium Line of Wellness ProductsBarrick Lauds Launch of Global Tailings Management Standard
